Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Cross-regulation of signaling pathways: an example of nuclear hormone receptors and the canonical Wnt pathway.

Beildeck ME, Gelmann EP, Byers SW.

Exp Cell Res. 2010 Jul 1;316(11):1763-72. doi: 10.1016/j.yexcr.2010.02.001. Review.

2.

The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.

Schweizer L, Rizzo CA, Spires TE, Platero JS, Wu Q, Lin TA, Gottardis MM, Attar RM.

BMC Cell Biol. 2008 Jan 24;9:4. doi: 10.1186/1471-2121-9-4.

3.

Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?

Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC.

Endocr Rev. 2005 Dec;26(7):898-915. Review.

PMID:
16126938
4.

Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.

Terry S, Yang X, Chen MW, Vacherot F, Buttyan R.

J Cell Biochem. 2006 Oct 1;99(2):402-10. Review.

PMID:
16741972
5.

Roles and regulation of Wnt signaling and beta-catenin in prostate cancer.

Verras M, Sun Z.

Cancer Lett. 2006 Jun 8;237(1):22-32. Review.

PMID:
16023783
6.

Wnt signaling from membrane to nucleus: β-catenin caught in a loop.

Jamieson C, Sharma M, Henderson BR.

Int J Biochem Cell Biol. 2012 Jun;44(6):847-50. doi: 10.1016/j.biocel.2012.03.001. Review.

PMID:
22433990
7.
8.
10.

WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.

Bisson I, Prowse DM.

Cell Res. 2009 Jun;19(6):683-97. doi: 10.1038/cr.2009.43.

PMID:
19365403
11.

Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways.

Singh R, Bhasin S, Braga M, Artaza JN, Pervin S, Taylor WE, Krishnan V, Sinha SK, Rajavashisth TB, Jasuja R.

Endocrinology. 2009 Mar;150(3):1259-68. doi: 10.1210/en.2008-0858.

12.

Novel regulatory mechanism of canonical Wnt signaling by dopamine D2 receptor through direct interaction with beta-catenin.

Min C, Cho DI, Kwon KJ, Kim KS, Shin CY, Kim KM.

Mol Pharmacol. 2011 Jul;80(1):68-78. doi: 10.1124/mol.111.071340.

13.

[Wnt signaling pathway--its role in regulation of cell metabolism].

Koziński K, Dobrzyń A.

Postepy Hig Med Dosw (Online). 2013 Nov 26;67:1098-108. Review. Polish.

14.

Simplet/Fam53b is required for Wnt signal transduction by regulating β-catenin nuclear localization.

Kizil C, Küchler B, Yan JJ, Özhan G, Moro E, Argenton F, Brand M, Weidinger G, Antos CL.

Development. 2014 Sep;141(18):3529-39. doi: 10.1242/dev.108415.

16.

Redundant expression of canonical Wnt ligands in human breast cancer cell lines.

Benhaj K, Akcali KC, Ozturk M.

Oncol Rep. 2006 Mar;15(3):701-7.

PMID:
16465433
17.

Orphan nuclear receptor TLX activates Wnt/beta-catenin signalling to stimulate neural stem cell proliferation and self-renewal.

Qu Q, Sun G, Li W, Yang S, Ye P, Zhao C, Yu RT, Gage FH, Evans RM, Shi Y.

Nat Cell Biol. 2010 Jan;12(1):31-40; sup pp 1-9. doi: 10.1038/ncb2001.

18.

Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer.

Wang G, Wang J, Sadar MD.

Cancer Res. 2008 Dec 1;68(23):9918-27. doi: 10.1158/0008-5472.CAN-08-1718.

19.

Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway.

Liu S, Vinall RL, Tepper C, Shi XB, Xue LR, Ma AH, Wang LY, Fitzgerald LD, Wu Z, Gandour-Edwards R, deVere White RW, Kung HJ.

Oncogene. 2008 Jan 17;27(4):499-505.

PMID:
17653089
20.

The low-density lipoprotein receptor-related protein 10 is a negative regulator of the canonical Wnt/beta-catenin signaling pathway.

Jeong YH, Sekiya M, Hirata M, Ye M, Yamagishi A, Lee SM, Kang MJ, Hosoda A, Fukumura T, Kim DH, Saeki S.

Biochem Biophys Res Commun. 2010 Feb 19;392(4):495-9. doi: 10.1016/j.bbrc.2010.01.049.

PMID:
20093106
Items per page

Supplemental Content

Support Center